SERB has a substantial European commercial presence and a successful track record in critical care and rare disease commercialization
BMS is moving beyond conversational AI into what it describes as “agentic” systems
The two companies will establish a joint Center of Excellence (CoE) in Bengaluru
Veteran biopharma leader stressed that generic medicines must be viewed separately from biologics
At India Pharma 2026, Dr Bahl calls for experimentation over imitation as funding rises and translational ecosystem reforms gather pace
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
Asahi Kasei is consistently pursuing its strategy of building a focused, sustainable specialty pharmaceutical platform for immunocompromised and medically complex patient groups
The announcement follows a record-setting $1.2 million accelerated LineaDNA order
Subscribe To Our Newsletter & Stay Updated
